As used in ORS 689.770 to 689.780, “the Charitable Prescription Drug Program” means a drug outlet that has: (1) A valid certificate of registration issued by the State Board of Pharmacy; (2) Volunteered to participate in the Charitable Prescription Drug Program; and (3) Been approved by the board to accept and distribute to needy individuals […]
(1) There is created in the State Board of Pharmacy the Charitable Prescription Drug Program. The purpose of the program is to distribute donated prescription drugs to needy or uninsured individuals. Participation in the program is voluntary. (2) The program may accept and distribute within this state: (a) Prescription drugs received as donations in original, […]
The State Board of Pharmacy shall adopt rules to carry out ORS 689.770 to 689.780, including but not limited to: (1) Specifying categories of prescription drugs that the Charitable Prescription Drug Program may not distribute under the program; (2) Prescribing the forms described in ORS 689.772; (3) Establishing the criteria for licensure and regulation under […]
The State Board of Pharmacy shall ensure compliance with ORS 689.770 to 689.780 by: (1) Inspecting the Charitable Prescription Drug Program on a regular basis; and (2) Auditing records required to be maintained by a pharmacy in connection with the program. [2009 c.300 §5]
An individual is eligible to obtain donated prescription drugs through the Charitable Prescription Drug Program created in ORS 689.772 if the individual: (1) Is a resident of this state; and (2)(a) Does not have health insurance coverage for the prescription drug requested; (b) Is enrolled in a program of public assistance, as defined in ORS […]
(1) As used in this section, “participant” means: (a) A person who donates a prescription drug to the Charitable Prescription Drug Program; (b) The Charitable Prescription Drug Program; (c) The State Board of Pharmacy; (d) A pharmacist; (e) A drug manufacturer; or (f) A health practitioner. (2) A participant who accepts or distributes donated prescription […]
